Quinolones - Drug of choice for enteric fever? [2]

Indian Journal of Medical Microbiology

Volumn 22, Issue 4, 2004, Pages 271-272

  Joshi, S ^a   Wattal, C ^a   Sharma, A ^a   Oberoi, J K ^a   Prasad, K J ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD SAMPLING; CONTROLLED STUDY; LABORATORY TEST; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 6944255180     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001;7:448-50.
2. Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 1999;37:3572-3577.
3. Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003; 36 535.
4. Chandel DS, Chaudhary R. Enteric fever treatment failures: a global concern. Emerg Infect Dis. 2001;7:762-3.
5. Chandel DS, Chaudhary R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000;6:420-421.